FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
Price range: $125.00 through $175.00
Lost, stolen, or damaged? We replace it, on us.
Pick your speed at checkout.
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
Glow Blend is a research compound blend that combines GHK-Cu, BPC-157 and TB-500, supplied by Peppy Peptides for laboratory research use only. Glow Blend is intended for qualified researchers studying cellular-signaling and tissue-remodeling pathways in controlled laboratory settings.
Glow Blend combines three separately characterized research peptides:
Combining the three peptides in one formulation lets laboratories study how these pathways interact.
Glow Blend is studied in laboratory research on the combined interaction of copper-dependent, growth-factor and cytoskeletal-regulation mechanisms. Each component is associated with a different area of research:
Laboratories studying where these three pathway families intersect use Glow Blend as a single-source multi-peptide research tool, within in-vitro or non-human in-vivo models and often alongside comparative single-peptide controls.
Glow Blend combines GHK-Cu, BPC-157 and TB-500, three research peptides studied for their interaction with cellular-signaling and tissue-remodeling pathways.
A blend lets researchers examine copper-dependent, growth-factor and cytoskeletal-regulation pathways within one research model. Single-peptide controls are often run alongside it for comparison.
Published laboratory research on GHK-Cu is indexed on PubMed.
Related Research Compounds: CJC-1295 / Ipamorelin – 10mg / 10mg • NAD+ – 1000mg • Browse all Best Sellers research compounds
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Lab-verified quality
Each lot is analysed by Bioviridian before release. Below is the Certificate of Analysis for the most recent lot, as issued by the laboratory.
Overall purity
99.8%
RP-HPLC (214 nm)
View the signed COA (PDF)Check this certificate at bioviridians.com/coa-search.html with code COA7689.
Test results
5 of 5 conformHPLC retention time 1.920, 9.098, 9.186 min · Signed: Shane Straight, M.S., Principal Chemist, Bioviridian Inc.
Every lot keeps its own signed certificate. Lots are listed newest first.
Lot GLOW072026-MG
99.8%
Overall purity
Tested July 13, 2026
Open COAEarlier lots will appear here as new Certificates of Analysis are published.
Compound details
Molecular profile
Storage requirements
Store lyophilised Glow Blend at −20°C for long-term stability prior to reconstitution.
Refrigerate at 2–8°C after reconstitution and use within 4–6 weeks; avoid repeated freeze-thaw cycles, protect the reconstituted solution from prolonged light exposure.
Published literature
5 peer-reviewed publications indexed on PubMed. Listed for reference only; inclusion does not imply any use, effect or endorsement.
FEBS LETT · 1988 GHK-Cu
Maquart FX, Pickart L, Laurent M, et al. FEBS Lett. 1988;238(2):343-346. doi:10.1016/0014-5793(88)80509-x
Measured collagen synthesis in cultured human fibroblasts exposed to the GHK-Cu complex across a range of concentrations.
CURR PHARM DES · 2014 BPC-157
Seiwerth S, Brcic L, Vuletic LB, et al. Curr Pharm Des. 2014;20(7):1121-5. doi:10.2174/13816128113199990421
Reviewed published laboratory and preclinical research on BPC 157 in relation to blood-vessel biology.
CURR PHARM DES · 2014 BPC-157
Stable gastric pentadecapeptide BPC 157-NO-system relation
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2014;20(7):1126-35. doi:10.2174/13816128113190990411
Reviewed research on the relationship between BPC 157 and the nitric oxide (NO) system.
NEURAL REGEN RES · 2022 BPC-157
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al. Neural Regen Res. 2022;17(3):482-487. doi:10.4103/1673-5374.320969
Reviewed preclinical research on BPC 157 in relation to the central nervous system.
THE JOURNAL OF BIOLOGICAL CHEMISTRY · 1991 TB-500 / Thymosin beta-4
Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable
Safer D, Elzinga M, Nachmias VT The Journal of biological chemistry. 1991;266(7):4029-32.
Sequenced the platelet actin-sequestering peptide Fx, identified it as thymosin beta-4, and characterized its 1:1 binding to G-actin and inhibition of actin polymerization.
